BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 18454852)

  • 1. Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism.
    Androutsopoulos V; Arroo RR; Hall JF; Surichan S; Potter GA
    Breast Cancer Res; 2008; 10(3):R39. PubMed ID: 18454852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells.
    Androutsopoulos VP; Ruparelia K; Arroo RR; Tsatsakis AM; Spandidos DA
    Toxicology; 2009 Oct; 264(3):162-70. PubMed ID: 19666078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
    Androutsopoulos VP; Papakyriakou A; Vourloumis D; Spandidos DA
    Bioorg Med Chem; 2011 May; 19(9):2842-9. PubMed ID: 21482471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1-mediated metabolism to the product 4' hydroxy tangeretin.
    Surichan S; Arroo RR; Tsatsakis AM; Androutsopoulos VP
    Toxicol In Vitro; 2018 Aug; 50():274-284. PubMed ID: 29626627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 CYP1 metabolism of hydroxylated flavones and flavonols: Selective bioactivation of luteolin in breast cancer cells.
    Wilsher NE; Arroo RR; Matsoukas MT; Tsatsakis AM; Spandidos DA; Androutsopoulos VP
    Food Chem Toxicol; 2017 Dec; 110():383-394. PubMed ID: 29097115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nobiletin bioactivation in MDA-MB-468 breast cancer cells by cytochrome P450 CYP1 enzymes.
    Surichan S; Arroo RR; Ruparelia K; Tsatsakis AM; Androutsopoulos VP
    Food Chem Toxicol; 2018 Mar; 113():228-235. PubMed ID: 29408579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation.
    Androutsopoulos VP; Mahale S; Arroo RR; Potter G
    Oncol Rep; 2009 Jun; 21(6):1525-8. PubMed ID: 19424633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The methoxylated flavones eupatorin and cirsiliol induce CYP1 enzyme expression in MCF7 cells.
    Androutsopoulos VP; Li N; Arroo RR
    J Nat Prod; 2009 Aug; 72(8):1390-4. PubMed ID: 19601638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzo[a]pyrene sensitizes MCF7 breast cancer cells to induction of G1 arrest by the natural flavonoid eupatorin-5-methyl ether, via activation of cell signaling proteins and CYP1-mediated metabolism.
    Androutsopoulos VP; Tsatsakis AM
    Toxicol Lett; 2014 Oct; 230(2):304-13. PubMed ID: 23994263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
    Chang TK; Chen J; Yang G; Yeung EY
    J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of eupatorin in MCF-7 and MDA-MB-231 human breast cancer cells via cell cycle arrest, anti-angiogenesis and induction of apoptosis.
    Razak NA; Abu N; Ho WY; Zamberi NR; Tan SW; Alitheen NB; Long K; Yeap SK
    Sci Rep; 2019 Feb; 9(1):1514. PubMed ID: 30728391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.
    Spink DC; Spink BC; Cao JQ; DePasquale JA; Pentecost BT; Fasco MJ; Li Y; Sutter TR
    Carcinogenesis; 1998 Feb; 19(2):291-8. PubMed ID: 9498279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells.
    Loaiza-Pérez AI; Kenney S; Boswell J; Hollingshead M; Alley MC; Hose C; Ciolino HP; Yeh GC; Trepel JB; Vistica DT; Sausville EA
    Mol Cancer Ther; 2004 Jun; 3(6):715-25. PubMed ID: 15210858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactivation of the phytoestrogen diosmetin by CYP1 cytochromes P450.
    Androutsopoulos V; Wilsher N; Arroo RR; Potter GA
    Cancer Lett; 2009 Feb; 274(1):54-60. PubMed ID: 18976853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of CYP1A1, CYP1A2 and CYP1B1 expression by cabbage juices and indoles in human breast cell lines.
    Szaefer H; Licznerska B; Krajka-Kuźniak V; Bartoszek A; Baer-Dubowska W
    Nutr Cancer; 2012 Aug; 64(6):879-88. PubMed ID: 22716309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells.
    Brantley E; Trapani V; Alley MC; Hose CD; Bradshaw TD; Stevens MF; Sausville EA; Stinson SF
    Drug Metab Dispos; 2004 Dec; 32(12):1392-401. PubMed ID: 15355884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
    Iwanari M; Nakajima M; Kizu R; Hayakawa K; Yokoi T
    Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent inhibition of carcinogen-bioactivating cytochrome P450 1B1 by the p53 inhibitor pifithrin alpha.
    Sparfel L; Van Grevenynghe J; Le Vee M; Aninat C; Fardel O
    Carcinogenesis; 2006 Mar; 27(3):656-63. PubMed ID: 16258175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of several dioxin-like compounds on estrogen metabolism in the malignant MCF-7 and nontumorigenic MCF-10A human mammary epithelial cell lines.
    van Duursen MB; Sanderson JT; van der Bruggen M; van der Linden J; van den Berg M
    Toxicol Appl Pharmacol; 2003 Aug; 190(3):241-50. PubMed ID: 12902195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitidine Chloride-Induced CYP1 Enzyme Inhibition and Alteration of Estradiol Metabolism.
    Mao X; Wang J; Wang Q; Yang L; Li Y; Lin H; Peng Y; Zheng J
    Drug Metab Dispos; 2019 Aug; 47(8):919-927. PubMed ID: 31147316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.